TipRanks
Advertisement
Advertisement
CEL-SCI to launch FDA registration-enabling Phase 3 Confirmatory study
PremiumThe FlyCEL-SCI to launch FDA registration-enabling Phase 3 Confirmatory study
3M ago
CEL-SCI, Saudi Amarox hold strategic agreement signing at BIO 2026
Premium
The Fly
CEL-SCI, Saudi Amarox hold strategic agreement signing at BIO 2026
4M ago
CEL-SCI highlights dual-track strategy for Multikine
Premium
The Fly
CEL-SCI highlights dual-track strategy for Multikine
4M ago
CEL-SCI enters strategic agreement with Amarox over Multikine distribution
PremiumThe FlyCEL-SCI enters strategic agreement with Amarox over Multikine distribution
5M ago
CEL-SCI files to sell 3.44M shares of common stock
Premium
The Fly
CEL-SCI files to sell 3.44M shares of common stock
6M ago
One new option listing and  option delistings on January 20th
Premium
The Fly
One new option listing and option delistings on January 20th
9M ago
CEL-SCI reports Q3 EPS ($1.36) vs. ($4.18) last year
PremiumThe FlyCEL-SCI reports Q3 EPS ($1.36) vs. ($4.18) last year
1y ago
CEL-SCI files for breakthrough designation for Multikine in Saudi Arabia
Premium
The Fly
CEL-SCI files for breakthrough designation for Multikine in Saudi Arabia
1y ago
Cel Sci trading resumes
Premium
The Fly
Cel Sci trading resumes
1y ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―